Prevalence of functional esophageal disorders and associated clinical characteristics in patients with proton‐pump‐inhibitor‐unresponsive reflux symptoms

Abstract

AbstractBackground and AimPatients with proton‐pump‐inhibitor (PPI)‐unresponsive reflux symptoms, often caused by functional esophageal disorders (FED), are frequently encountered in clinical practice. We aimed to investigate the prevalence of FED and its associated clinical characteristics in patients with PPI‐unresponsive reflux symptoms.MethodsWe retrospectively identified patients who were evaluated for persistent typical reflux symptoms, despite ≥8 weeks of PPI treatment, at the National Taiwan University Hospital from 2014 to 2023. All patients underwent a comprehensive evaluation comprising validated gastroesophageal reflux disease (GERD) symptom questionnaires, 5‐item Brief Symptom Rating Scale (BSRS‐5), Pittsburgh Sleep Quality Index (PSQI), esophagogastroduodenoscopy, high‐resolution impedance manometry, and 24‐h impedance‐pH monitoring off PPI therapy. Diagnosis of FED and non‐erosive reflux disease (NERD) was based on the Rome IV criteria.ResultsWe analyzed 190 patients [46.8% male, median age 52 (interquartile range, 42–61) years], of whom 32 (16.8%) had NERD and 158 (83.2%) had FED (57.9% with functional heartburn and 25.3% with reflux hypersensitivity). Patients with FED had a lower body mass index than those with NERD and a higher prevalence of psychological comorbidities and poor sleep quality than healthy volunteers. The severity of reflux symptoms among FED patients was significantly associated with the severity of psychological comorbidities and sleep quality.ConclusionsA notably high prevalence (83.2%) of FED was observed among patients experiencing PPI‐unresponsive reflux symptoms. Patients with FED had a higher level of psychological distress and diminished sleep quality, both of which were associated with reflux symptom severity.